A prospective study of the feasibility of smartphone-based self-monitoring to characterise cognitive and neurological impairment in people with multiple sclerosis: Floodlight MS MoreActive
A description of the multicentre, prospective, noninterventional, primary data collection Floodlight MS MoreActive study, which evaluates the feasibility of Floodlight™ MS assessments for characterising cognitive and neurological impairment and trajectories in people living with multiple sclerosis. The study will last approximately 4 years, recruiting 600 people with multiple sclerosis to measure disease trajectories from their use of three smartphone-based self-monitoring digital tools: Floodlight MS tests, MSReactor tests and Redenlab speech assessment. Study endpoints include cross-sectional and longitudinal correlations between digital outcome measures and cognitive and clinical outcome assessments, magnetic resonance imaging and patient reported outcome measures.
{{assetTitle}}
{{assetDescription}}
You are Leaving Medically
By following this link, you are leaving Roche Website and entering a site that is not owned or controlled by Roche. Roche does not take any responsibility for acces to or use of this website, nor for any content therein.
You are Leaving the Global Medically Site
By following this link, you are being redirected to another Roche page.